page_banner

Products

SARS-COV-2/Influenza A+B Antigen Combo Rapid Test Device


Short Description:

The Influenza A+B/COVID-19 Antigen Rapid Test Device is a rapid visual immunoassay for the qualitative, presumptive detection of influenza A and B viral antigens and COVID-19 Antigen form throat swabs and nasopharyngeal swab specimens. The test is intended for use as an aid in the rapid differential diagnosis of acute influenza type A and type B virus and COVID-19 infection.



Product Detail

Product Tags

PRODUCT SPECIFICATION

Brand

Funworld

Certificate

CE

Specimen

Nasopharyngeal swabs/ Nasal swab

Pack

20T

Reading Time

10 minutes

Contents

Cassette , Buffer ,Package insert

Storage

2-30℃

Shelf Life

2 years

INTERPRETATION OF RESULTS

Same test procedure As SARS-COV-2 Antigen Rapid Test Device (Swab), The result Should be read at 10 minutes, Do not interpret the result after 20 minutes.

CX1

Possible Interpretation of Test Results:Flu B Positive:* A colored band appears in the control band region (C) and another colored band appears in the B region.

CX2

Flu A Positive:* A colored band appears in the control band region (C) and anothere colored band appears in the A region.

CS3

Flu A+B Positive:* A colored band appears in the control band region (C) and two other colored bands appear in the A region and B regions, respectively.

CS3

COVID-19 Positive:* A colored band appears in the control band region (C) and another colored band appears in the N region.

CS3

NEGATIVE RESULT:Only one colored band appears, in the control band region (C). No band appears in either test band region (A/B/N).

csx1

INVALID RESULT: Control band fails to appear. Results from any test which has not produced a control band at the specified reading time must be discarded. Please review the procedure and repeat with a new test. If the problem persists, discontinue using the kit immediately and contact your local distributor.

PERFORMANCE CHARACTERISTICS

Table: Flu A+B Rapid Test vs. other commercial brand

zxcsd

  • Previous:
  • Next:


  • Previous:
  • Next: